Lamberto Andreotti, Bristol-Myers Squibb president and COO
Bristol-Myers Squibb is rearranging the top of its org chart. The biggest change: Bristol tapped COO Lamberto Andreotti (above), 58, as president and COO, and added him to the board of directors. That's raising speculation that Andreotti is also the chosen heir to CEO Jim Cornelius (photo). As the Wall Street Journal points out, Andreotti was one of the execs competing for the top job when Cornelius won it.
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
